127 related articles for article (PubMed ID: 37303676)
1. Efficacy of bumetanide tablets combined with valsartan in the treatment of elderly patients with chronic glomerulonephritis and its effects on renal function and hemodynamics.
Zhang S; Wang J; Liu Y; Yu X; Chen C
Am J Transl Res; 2023; 15(5):3424-3432. PubMed ID: 37303676
[TBL] [Abstract][Full Text] [Related]
2. Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).
Chen C; Wu X; Li Y; Peng Y
Ann Palliat Med; 2021 May; 10(5):5455-5461. PubMed ID: 34044572
[TBL] [Abstract][Full Text] [Related]
3. Clinical effect and safety of nifedipine controlled-release tablets combined with valsartan in the treatment of primary hypertension.
Liu W; Liu Y; Fu J
Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2419-2422. PubMed ID: 31894027
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of flunarizine tablets combined with betahistine hydrochloride tablets in patients with vertebrobasilar insufficiency vertigo.
Meng S; Liu Q; Zhang L
Am J Transl Res; 2022; 14(11):8183-8190. PubMed ID: 36505311
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of sacubitril/valsartan in peritoneal dialysis patients with HFpEF and its effect on residual renal function].
Ma JW; Ren LL; Huang JC; Bao SZ; Dai LL; Ying J; Bian XY
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(2):117-124. PubMed ID: 36597739
[No Abstract] [Full Text] [Related]
6. Effects of tanshinone combined with valsartan on hypertensive nephropathy and its influence on renal function and vascular endothelial function.
Chen L; Wu J; Xu H; Chen J; Xie X
Am J Transl Res; 2021; 13(5):4788-4795. PubMed ID: 34150059
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the improvement of serological indexes in patients with diabetic nephropathy and hypertension using Valsartan combined with Nifedipine controlled-release regimen.
Cai L; Zhu H
Pak J Med Sci; 2022; 38(6):1569-1574. PubMed ID: 35991228
[TBL] [Abstract][Full Text] [Related]
8. Effect of Nephritis Rehabilitation Tablets combined with tacrolimus in treatment of idiopathic membranous nephropathy.
Lv W; Wang MR; Zhang CZ; Sun XX; Yan ZZ; Hu XM; Wang TT
World J Clin Cases; 2021 Dec; 9(34):10464-10471. PubMed ID: 35004978
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Yishen Huashi Granules Combined with Linagliptin Tablets on Blood Glucose and Renal Function in Patients with Type 2 Diabetic Nephropathy.
Zhang P; Meng J; Duan M; Li D; Wang R
Comput Intell Neurosci; 2022; 2022():4272520. PubMed ID: 36177313
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
11. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
Plum J; Bünten B; Németh R; Grabensee B
J Am Soc Nephrol; 1998 Dec; 9(12):2223-34. PubMed ID: 9848776
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
Ng TM; Konopka E; Hyderi AF; Hshieh S; Tsuji Y; Kim BJ; Han SY; Phan DH; Jeng AI; Lou M; Elkayam U
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):345-53. PubMed ID: 23538300
[TBL] [Abstract][Full Text] [Related]
13. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
14. [Renal and uterine hemodynamics in pregnancy with chronic glomerulonephritis of the hypertonic type].
Rogov VA; Shilov EM; Sidorova IS; Rogova EF; Makarov IO; Zozulia OV
Ter Arkh; 2002; 74(10):52-5. PubMed ID: 12469633
[TBL] [Abstract][Full Text] [Related]
15. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
[TBL] [Abstract][Full Text] [Related]
16. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.
Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Gotoh A; Uchida K; Higaki J
Clin Exp Hypertens; 2006 Jul; 28(5):451-61. PubMed ID: 16820342
[TBL] [Abstract][Full Text] [Related]
17. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
[TBL] [Abstract][Full Text] [Related]
18. Benefits of sacubitril/valsartan use in patients with chronic heart failure after cardiac valve surgery: a single-center retrospective study.
Zheng J; Wu Q; Li Q; Tang M; He J; Qiu Z; Xie L; Chen L
J Cardiothorac Surg; 2023 Apr; 18(1):138. PubMed ID: 37041595
[TBL] [Abstract][Full Text] [Related]
19. Comparison of valsartan and benazepril when combined with atorvastatin in protecting patients with early cardio-renal syndrome (CRS).
Peng DF; Tang SY; Hu YJ; Chen J; Peng X; Huang Q
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1264-71. PubMed ID: 25912588
[TBL] [Abstract][Full Text] [Related]
20. The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure.
Du H; Li X; Zhao W; Jiang N
J Healthc Eng; 2022; 2022():9494981. PubMed ID: 35222898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
